Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-28

FDA Approved: VALTYA 1/35 — Original Application (Xiromed LLC)

View source ↗

Summary

FDA approved VALTYA 1/35, a generic combination oral contraceptive containing ethynodiol diacetate and ethinyl estradiol, from Xiromed LLC, under an original AN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALTYA 1/35 (Ethynodiol diacetate and Ethinyl estradiol)

Snippet

ORIG AP for VALTYA 1/35 (ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL)